MidFirst Bank acquired a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the fourth quarter, HoldingsChannel reports. The firm acquired 19,133 shares of the company’s stock, valued at approximately $1,282,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Brighton Jones LLC raised its stake in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP lifted its holdings in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after buying an additional 980 shares during the period. Cresset Asset Management LLC grew its holdings in shares of Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after buying an additional 181 shares in the last quarter. Finally, Jump Financial LLC acquired a new stake in Corteva in the 2nd quarter valued at approximately $1,464,000. 81.54% of the stock is owned by institutional investors and hedge funds.
Corteva Stock Down 0.0%
CTVA stock opened at $78.57 on Friday. The company has a market cap of $52.55 billion, a price-to-earnings ratio of 46.22, a P/E/G ratio of 2.40 and a beta of 0.57. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The business has a 50 day moving average price of $79.64 and a two-hundred day moving average price of $75.69. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.
Analysts Set New Price Targets
Several equities research analysts have commented on CTVA shares. The Goldman Sachs Group boosted their target price on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. CICC Research boosted their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Barclays increased their target price on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Finally, UBS Group decreased their target price on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research report on Tuesday, June 9th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.81.
Get Our Latest Stock Analysis on Corteva
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
- Five stocks we like better than Corteva
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
